The Malaysia Central Nervous System (CNS)Therapeutics Market was valued at $338 Mn in 2022 and is predicted to grow at a CAGR of 6.6% from 2023 to 2030, to $563 Mn by 2030. The key drivers of this industry include the rising prevalence of CNS disorders, supportive government initiatives, and rising disposable income. The industry is primarily dominated by players such as Abbott, Novartis, Merck, Eisai, AstraZeneca, Otsuka, Duopharma, and Pharmaniaga among others.
The Brazil Hospital Market was valued at $137.49 Bn in 2023 and is predicted to grow at a CAGR of 8.6% from 2023 to 2030, to $244.95 Bn by 2030. The key drivers of this industry are rise in the geriatric population, technological advancement, and government initiatives. The key players in the industry are Hospital São Rafael, Rede D'Or São Luiz, Hospital Alemão Oswaldo Cruz, and Hospital Samaritano among others.
The Mexico Central Nervous System (CNS)Therapeutics Market was valued at $3.150 Bn in 2022 and is predicted to grow at a CAGR of 6.65% from 2023 to 2030, to $5.272 Bn by 2030. The key drivers of this industry include the rising burden of CNS disorders, increasing healthcare accessibility, and technological advancements. The industry is primarily dominated by players such as Pfizer, Sunovion, Biogen, Genomma, Eli Lilly, Teva, GSK, and Otsuka among others.
The Saudi Arabia Hemodialysis Equipment Market was valued at $240 Mn in 2023 and is projected to grow at a CAGR of 9.1% from 2023 to 2023, to $441.6 Mn by 2030. The key drivers of this industry are increasing incidence of chronic kidney disease (CKD) and end-stage renal disease (ESRD), availability of advanced dialysis machines and consumables, government initiatives to improve dialysis accessibility, growing adoption of home haemodialysis, expansion of dialysis service providers which has contributed to market growth. The industry is primarily dominated by players such as Siemens Healthineers, Boston Scientific Corporation, Baxter, B. Braun SE, Fresenius Medical Care AG, Medtronic, Asahi Kasei Medical Co., Ltd, Nipro Corp among others.
The Mexico Hospital Market was valued at $82.49 Bn in 2023 and is predicted to grow at a CAGR of 7.85% from 2023 to 2030, to $140.01 Bn by 2030. The key drivers of this industry rise in rise in geriatric population, medical tourism, and government support. The key players in the industry are Galenia Hospital, Hospital Español, Médica Sur, and Star Médica Monterrey among others.
Philippines Breastfeeding Accessories Market was valued at $5.52 Mn in 2023 and is predicted to grow at a CAGR of 7.30% from 2023 to 2030, to $9.04 Mn by 2030. The key drivers of this industry include government initiatives and policies, an increasing number of working mothers, and technological advancements. The industry is primarily dominated by Medala, Elvie, Willow Innovations, and Koninklijke Philips among others.
The Philippines Central Nervous System (CNS)Therapeutics Market was valued at $462 Mn in 2022 and is predicted to grow at a CAGR of 6.9% from 2023 to 2030, to $788 Mn by 2030. The key drivers of this industry include the rising prevalence of CNS disorders, increasing healthcare infrastructure, and expanding pharmaceutical landscape. The industry is primarily dominated by players such as Abbott, Novartis, Merck, Eisai, AstraZeneca, United Laboratories, and CIG Philippines among others.
The UAE Hemodialysis Equipment Market was valued at $70.6 Mn in 2023 and is projected to grow at a CAGR of 8.6% from 2023 to 2023, to $125.8 Mn by 2030. The key drivers of this industry are increasing incidence of chronic kidney disease (CKD) and end-stage renal disease (ESRD), availability of advanced dialysis machines and consumables, government initiatives to improve dialysis accessibility, growing adoption of home haemodialysis, expansion of dialysis service providers which has contributed to market growth. The industry is primarily dominated by players such as Baxter, B. Braun SE, Fresenius Medical Care AG, Medtronic, Asahi Kasei Medical Co., Ltd, Nipro Corp, DaVita, Quanta Dialysis Technologies among others.
The France Hospital Market was valued at $151.24 Bn in 2023 and is predicted to grow at a CAGR of 6.6% from 2023 to 2030, to $236.57 Bn by 2030. The key drivers of this industry are increase in incidences of chronic diseases, technological advancements, and rising healthcare spending. The key players in the industry are American Hospital of Paris, Geoffroy Saint Hilaire Clinic, Hôpital Privé Jean Mermoz, and Hôpital Lenval among others.
Vietnam Breastfeeding Accessories Market was valued at $12.55 Mn in 2023 and is predicted to grow at a CAGR of 7.03% from 2023 to 2030, to $20.19 Mn by 2030. The key drivers of this industry include Increasing Awareness, Rising Number of Working Mothers, and Urbanization and Changing Lifestyles. The industry is primarily dominated by Medala, Elvie, Willow Innovations, and Koninklijke Philips among others.
The Saudi Arabia Central Nervous System (CNS)Therapeutics Market was valued at $3.570 Bn in 2022 and is predicted to grow at a CAGR of 7.9% from 2023 to 2030, to $6.559 Bn by 2030. The key drivers of this industry include the rising burden of CNS diseases, expanding healthcare spending, and technological advancements in the industry. The industry is primarily dominated by players such as Pfizer, Novartis, Hikma Pharmaceutical, Otsuka, AbbVie, and Eli Lilly among others.
The Brazil Hemodialysis Equipment Market was valued at $353 Mn in 2023 and is projected to grow at a CAGR of 8.6% from 2023 to 2023, to $628.9 Mn by 2030. The key drivers of this industry are increasing incidence of chronic kidney disease (CKD) and end-stage renal disease (ESRD), availability of advanced dialysis machines and consumables, government initiatives to improve dialysis accessibility, growing adoption of home haemodialysis, expansion of dialysis service providers which has contributed to market growth. The industry is primarily dominated by players such as Dialife, Renaltech, Biomed, Baxter, B. Braun SE, Fresenius Medical Care AG, Medtronic Ltd among others.
The Germany Hospital Market was valued at $201.28 Bn in 2023 and is predicted to grow at a CAGR of 5.8% from 2023 to 2030, to $298.68 Bn by 2030. The key drivers of this industry are government investment, aging population, and emphasis on innovation. The key players in the industry are Helios Kliniken, Asklepios Kliniken, Sana Kliniken, and University Hospital Dusseldorf among others.
Egypt Breastfeeding Accessories Market was valued at $7.03 Mn in 2023 and is predicted to grow at a CAGR of 8.30% from 2023 to 2030, to $12.28 Mn by 2030. The key drivers of this industry include increasing awareness of breastfeeding benefits, a rising middle-class population, and improved healthcare infrastructure. The industry is primarily dominated by Medala, Elvie, Willow Innovations, and Koninklijke Philips among others.
The Singapore Central Nervous System (CNS)Therapeutics Market was valued at $252 Mn in 2022 and is predicted to grow at a CAGR of 7% from 2023 to 2030, to $433 Mn by 2030. The key drivers of this industry include the increasing prevalence of CNS disorders, increasing government initiatives, and growing awareness and diagnoses. The industry is primarily dominated by players such as AbbVie, Novartis, Merck, AstraZeneca, Teva, and Eli Lilly among others.
The Spain Hospital Market was valued at $106.14 Bn in 2023 and is predicted to grow at a CAGR of 6.6% from 2023 to 2030, to $166.03 Bn by 2030. The key drivers of this industry are rise in geriatric population, technological advancements, and medical tourism. The key players in the industry are Quirónsalud, Hospital Ruber Internacional, HM Hospitales, and Hospital HLA Moncloa among others.
Kenya Breastfeeding Accessories Market was valued at $1.76 Mn in 2023 and is predicted to grow at a CAGR of 7.90% from 2023 to 2030, to $2.99 Mn by 2030. The key drivers of this industry include increasing awareness and health education, rising disposable income, and urbanization and modern lifestyle. The industry is primarily dominated by Medala, Elvie, Willow Innovations, and Koninklijke Philips among others.
The South Africa Central Nervous System (CNS)Therapeutics Market was valued at $1.365 Bn in 2022 and is predicted to grow at a CAGR of 7.63% from 2023 to 2030, to $2.458 Bn by 2030. The key drivers of this industry include the increasing prevalence of CNS disorders, supportive government initiatives, and growing awareness. The industry is primarily dominated by players such as Novartis, Sanofi, AstraZeneca, Pfizer, and Roche among others.
The Spain GvHD Therapeutics Market was valued at $48.25 Mn in 2023 and is predicted to grow at a CAGR of 7.1% from 2023 to 2030, to $77.99 Mn by 2030. The growth in the Spanish market is driven by various factors like the rise in chronic GvHD cases, advanced technology, increasing awareness, government support, and the increasing prevalence of blood diseases. The major competitors in the market are Merck, Sanofi, Pfizer, Novartis, Mallinckrodt, Incyte, Abbott, and Takeda among others.
The UK Hospital Market was valued at $142.99 Bn in 2023 and is predicted to grow at a CAGR of 5.6% from 2023 to 2030, to $209.39 Bn by 2030. The key drivers of this industry are rise in geriatric population, technological advancements, and government initiatives. The key players in the industry are Royal Brompton & Harefield Hospitals Specialist Care, London Bridge Hospital, Nuffield Health Cambridge Hospital, and Bupa Cromwell Hospital among others.
South Africa Breastfeeding Accessories Market was valued at $16.32 Mn in 2023 and is predicted to grow at a CAGR of 8.03% from 2023 to 2030, to $28.02 Mn by 2030. The key drivers of this industry include government initiatives and health programs, raising awareness and education, and increasing the number of working mothers. The industry is primarily dominated by Medala, Elvie, Willow Innovations, and Koninklijke Philips among others.
The Spain Central Nervous System (CNS)Therapeutics Market was valued at $4.053 Bn in 2022 and is predicted to grow at a CAGR of 5.4% from 2023 to 2030, to $6.173 Bn by 2030. The key drivers of this industry include the surge in the prevalence of CNS disorders, increased healthcare expenditure, and technological advancements in the industry. The industry is primarily dominated by players such as AbbVie, Pfizer, Eli Lilly, Grunenthal, Teva, Biogen, and Novartis among others.
The UAE GvHD Therapeutics Market was valued at $12.5 Mn in 2023 and is predicted to grow at a CAGR of 9.1% from 2023 to 2030, to $23 Mn by 2030. The drivers responsible for growth are the increasing prevalence of blood diseases, specialized treatments, and competitive landscapes. The key competitors are JCR, Takeda, Janssen, MaaT, XeniKos, Medac, Incyte, Mesoblast and others.
The China Hospital Market was valued at $442.09 Bn in 2023 and is predicted to grow at a CAGR of 9.1% from 2023 to 2030, to $813.37 Bn by 2030. The key drivers of this industry are rise in geriatric population, increase in healthcare awareness, and government investment. The key players in the industry are United Family Healthcare, Aier Eye Hospital Group, Rici Healthcare Holdings, and Hua Sheng Group among others.
India Breastfeeding Accessories Market was valued at $45.65 Mn in 2023 and is predicted to grow at a CAGR of 9.80% from 2023 to 2030, to $87.83 Mn by 2030. The key drivers of this industry include urbanization and working mothers, technological advancements in products, and increasing disposable income. The industry is primarily dominated by Medala, Elvie, Willow Innovations, and Koninklijke Philips among others.